Found 6 matching trials
Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted PHASE1 Despite having developed robust acquired immunity against complications of ...
Show More Location
Institut de Recherche Clinique du Benin (IRCB)
Learn More & Join Trial
The Effects of GLA on Human Volunteers PHASE1 The advent of vaccines contributed to major improvements in human morbidity...
Show More Location
The Rockefeller University
Learn More & Join Trial
Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children PHASE2 The clinical trial phase 2b is designed to assess the safety and the specif...
Show More Location
Biomedical Research Center EPLS
Learn More & Join Trial
ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 PHASE1 The purpose of this study is to evaluate the safety and explore the immunog...
Show More Location
Chung-Ang University Gwangmyeong Hospital
Learn More & Join Trial
Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults PHASE1 The primary objective is to evaluate the safety of 3 doses given at D0, W4,...
Show More Learn More & Join Trial
Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions PHASE2 The clinical trial phase 2a is designed to assess the safety of the active ...
Show More Location
Biomedical Research Center EPLS
Learn More & Join Trial